Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01649089 · ClinicalTrials.gov registry record · NA
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
A NA study of Lymphedema and Cervical Squamous Cell Carcinoma, sponsored by GOG Foundation.
- Active
- Registry status
- NA
- Development phase
- 224
- Enrollment target
- 20
- Study locations
NCT01649089: Active NA study of Lymphedema and Cervical Squamous Cell Carcinoma, sponsored by GOG Foundation.
NCT01649089 is a NA study of Lymphedema and Cervical Squamous Cell Carcinoma that is active but no longer recruiting, run by GOG Foundation. The registered enrollment target is 224 participants, below the 9,293-participant average among 34 other Lymphedema trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01649089, a NA study of Lymphedema and Cervical Squamous Cell Carcinoma, is active but no longer recruiting, sponsored by GOG Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial studies the physical function and quality-of-life before and after surgery in patients with stage I cervical cancer. Studying quality-of-life in patients undergoing surgery for cervical cancer may help determine the intermediate-term and long-term effects of surgery.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Conization
- PROCEDURE Therapeutic Lymphadenectomy
Study Locations (20)
California
- Sutter Auburn Faith Hospital - Auburn
- Sutter Cancer Centers Radiation Oncology Services-Auburn - Auburn
- Alta Bates Summit Medical Center-Herrick Campus - Berkeley
- Mills-Peninsula Medical Center - Burlingame
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park - Cameron Park
- Eden Hospital Medical Center - Castro Valley
- Sutter Davis Hospital - Davis
- Palo Alto Medical Foundation-Fremont - Fremont
- UC San Diego Moores Cancer Center - La Jolla
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Memorial Medical Center - Modesto
- Palo Alto Medical Foundation-Camino Division - Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology - Mountain View
- UC Irvine Health/Chao Family Comprehensive Cancer Center - Orange
- Palo Alto Medical Foundation Health Care - Palo Alto
- Sutter Cancer Centers Radiation Oncology Services-Roseville - Roseville
- Sutter Roseville Medical Center - Roseville
- Sutter Medical Center Sacramento - Sacramento
Arizona
- Cancer Center at Saint Joseph's - Phoenix
- Saint Joseph's Hospital and Medical Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2013-06-05 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What the registry record for NCT01649089 still lists
NCT01649089 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 9,293-participant average among 34 other Lymphedema trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Lymphedema appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01649089 names 20 study sites across 2 states, led by California, Arizona.
Frequently Asked Questions
What is clinical trial NCT01649089 about?
NCT01649089 is a clinical study titled "Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer". This clinical trial studies the physical function and quality-of-life before and after surgery in patients with stage I cervical cancer. Studying quality-of-life in patients undergoing surgery for cervical cancer may help determine the intermediate-term and long-term effects of surgery.
What is the current status of trial NCT01649089?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2013-06-05. Estimated completion is 2025-12-01.
What conditions does trial NCT01649089 study?
This clinical trial studies the following conditions: Lymphedema, Cervical Squamous Cell Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Stage IA1 Cervical Cancer AJCC v6 and v7.
What interventions are being tested in trial NCT01649089?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Therapeutic Conventional Surgery (PROCEDURE), Conization (PROCEDURE), Therapeutic Lymphadenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01649089?
This trial is sponsored by GOG Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01649089 being conducted?
This trial has 20 study locations across Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01649089's enrollment target sits among peer trials
224 13th of 34 higher than 22 of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI